Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 25

1.

Brain nicotinic acetylcholine receptor occupancy: effect of smoking a denicotinized cigarette.

Brody AL, Mandelkern MA, Costello MR, Abrams AL, Scheibal D, Farahi J, London ED, Olmstead RE, Rose JE, Mukhin AG.

Int J Neuropsychopharmacol. 2009 Apr;12(3):305-16. doi: 10.1017/S146114570800922X. Epub 2008 Aug 18.

2.

In vivo brain imaging of human exposure to nicotine and tobacco.

Sharma A, Brody AL.

Handb Exp Pharmacol. 2009;(192):145-71. doi: 10.1007/978-3-540-69248-5_6. Review.

3.

Recent PET radioligands with optimal brain kinetics for imaging nicotinic acetylcholine receptors.

Horti AG, Kuwabara H, Holt DP, Dannals RF, Wong DF.

J Labelled Comp Radiopharm. 2013 Mar-Apr;56(3-4):159-66. doi: 10.1002/jlcr.3020. Review.

PMID:
24285321
4.

Disrupting nicotine reinforcement: from cigarette to brain.

Rose JE.

Ann N Y Acad Sci. 2008 Oct;1141:233-56. doi: 10.1196/annals.1441.019. Review.

PMID:
18991961
5.

Neural bases of pharmacological treatment of nicotine dependence - insights from functional brain imaging: a systematic review.

Menossi HS, Goudriaan AE, de Azevedo-Marques Périco C, Nicastri S, de Andrade AG, D'Elia G, Li CS, Castaldelli-Maia JM.

CNS Drugs. 2013 Nov;27(11):921-41. doi: 10.1007/s40263-013-0092-8. Review.

PMID:
23853032
6.

Recent advances in understanding nicotinic receptor signaling mechanisms that regulate drug self-administration behavior.

Tuesta LM, Fowler CD, Kenny PJ.

Biochem Pharmacol. 2011 Oct 15;82(8):984-95. doi: 10.1016/j.bcp.2011.06.026. Epub 2011 Jun 29. Review.

7.

Radioligand imaging of α4β2* nicotinic acetylcholine receptors in Alzheimer's disease and Parkinson's disease.

Meyer PM, Tiepolt S, Barthel H, Hesse S, Sabri O.

Q J Nucl Med Mol Imaging. 2014 Dec;58(4):376-86. Epub 2014 Nov 11. Review.

PMID:
25387119
8.

Dual role of nicotine in addiction and cognition: a review of neuroimaging studies in humans.

Jasinska AJ, Zorick T, Brody AL, Stein EA.

Neuropharmacology. 2014 Sep;84:111-22. doi: 10.1016/j.neuropharm.2013.02.015. Epub 2013 Mar 6. Review.

9.

[18F]Norchloro-fluoro-homoepibatidine .

Leung K.

Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.
2008 Aug 12 [updated 2008 Aug 22].

10.

(-)-7-Methyl-2-exo-[3'-(6-[18F]fluoropyridin-2-yl)-5'-pyridinyl]-7-azabicyclo[2.2.1]heptane.

Leung K.

Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.
2009 Apr 12 [updated 2009 Apr 3].

11.

[18F]5-(6-Fluorohexyn-1-yl)-3-[2(S)-2-azetidinylmethoxy]pyridine.

Leung K.

Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.
2009 Nov 12 [updated 2010 Jan 14].

12.

Orthosteric and Allosteric Ligands of Nicotinic Acetylcholine Receptors for Smoking Cessation.

Mohamed TS, Jayakar SS, Hamouda AK.

Front Mol Neurosci. 2015 Nov 25;8:71. doi: 10.3389/fnmol.2015.00071. eCollection 2015. Review.

13.

PET Imaging of the Human Nicotinic Cholinergic Pathway in Atherosclerosis.

Bauwens M, Mottaghy FM, Bucerius J.

Curr Cardiol Rep. 2015 Aug;17(8):67. doi: 10.1007/s11886-015-0614-8. Review.

14.

2-(+/-)-2-exo-(2'-[18F]Fluoro-3'-phenyl-pyridin-5'-yl)-7-azabicyclo[2.2.1]heptane.

Leung K.

Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.
2006 Oct 6 [updated 2006 Dec 4].

15.

2-[18F]Fluoro-3-[2(S)-2-azetidinylmethoxy]pyridine.

Leung K.

Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.
2006 Jun 23 [updated 2008 Apr 8].

16.

Nicotine withdrawal.

McLaughlin I, Dani JA, De Biasi M.

Curr Top Behav Neurosci. 2015;24:99-123. doi: 10.1007/978-3-319-13482-6_4. Review.

17.

6-[18F]Fluoro-3-[2(S)-2-azetidinylmethoxy]pyridine.

Leung K.

Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.
2006 Jun 26 [updated 2008 Apr 11].

18.

5-[123I]Iodo-3-[2(S)-2-azetidinylmethoxy]pyridine .

Leung K.

Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.
2006 Jul 7 [updated 2006 Jul 24].

19.

3-(2-(S)-3,4-Dehydropyrrolinyl methoxy)-5-(3'-[18F]fluoropropyl)pyridine.

Leung K.

Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.
2013 Mar 18 [updated 2013 May 23].

20.

5-3’-[18F]Fluoropropyl-3-[2-((S)-pyrrolidinyl)methoxy]pyridine.

Leung K.

Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.
2006 Sep 18 [updated 2012 Apr 3].

Supplemental Content

Support Center